Global Gene Therapy Market Analysis, Phases, Key Company and Forecast to 2022

Global Gene Therapy Market Analysis & Forecast to 2022 research report provides Gene Therapy Phases, Strength of Gene Therapy Industry, Vectors for Gene Delivery, Clinical Applications, Key Company analysis and forecasts to 2022

Pune, India - November 14, 2018 /MarketersMedia/ —

In 2017, the gene therapy market for technologies, services and products was estimated to be worth $x million, with a potential to reach $363 million by 2022. The main market space is cancer which currently holds x% market share. This indication generated $x million in 2017 and will generate $x million in 2022. This is followed by rare diseases, cardiovascular, neurological and ocular indications. Looking at the market by technology, at present, gene product therapeutics generate the majority of revenue with over $x million in 2017, growing to $x million by 2022. Viral vectors are set to generate $x million in 2017, and will rise to $x million in 2022, and by then gene therapy services such as vector development and transfection will hit $x million. At present, the Americas have penetrated the market significantly with 65% geographic share, followed by Europe (x%) and the RoW (x%).

Company Profiles: 4d Molecular Therapeutics LLC, Abeona Therapeutics LLC, Advanced Cell & Gene Therapy LLC, Advantagene Inc., Adverum Biotechnologies Inc., Addgene Inc., Agilis Biotherapeutics LLC, Angionetics Inc., Applied Genetic Technologies Corporation (AGTC), AnGes MG Inc., Asklepios BioPharmaceutical Inc., Audentes Therapeutics Inc. and others…

Get Discount on Gene Therapy Market Analysis & Forecast to 2022 Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1370259

This report provides the reader with:

• Current Global Market Worth and Forecast with CAGR Through 2022
• Sub-Market Worth by Therapeutic Area (Cancer, Rare Diseases, Cardiovascular, Neurological, Ocular) and Forecast with CAGR Through 2022
• Sub-Market Worth by Geography (Americas, Europe, RoW) and Forecast with CAGR Through 2022
• Sub-Market Worth by Technology (Gene Product, Service, Viral Vectors) and Forecast with CAGR Through 2022
• Insight into gene therapy technologies, challenges associated with developing therapeutic genes and disadvantages of gene therapy.
• Full outline of the gene therapy industry from the formative years through to products discovered during 1990 and 2017.
• Detailed descriptions of commercialized products approved between 2003 and 2017 that include: Gendicine, Rexin-G, Oncorine, Neovasculgen, Glybera, Imlygic, Strimvelis, Zalmoxis, Kymriah, Yescarta and Luxturna.
• Description of seven of the Phase III product candidates that include: Generx, Collategene, LentiGlobin, Lenti-D, VM-202, Invosa and GS-010.
• Description of 21 Phase II product candidates that are set to have significant market share.
• Commercialization status of gene therapies in by geographic region
• Evaluation of gene therapy pricing
• Description of the firstever warranty offer by GSK for Strimvelis.
• A detailed analysis of various types of viruses used as vectors.
• Description of clinical applications of gene therapy and the various genetic and infectious diseases addressed by gene therapy.
• Description of 77 companies that are directly and indirectly associated with gene therapy industry.

Order a Complete Research Study of Gene Therapy Market Report at https://www.reportsnreports.com/purchase.aspx?name=1370259

Key Questions Answered in this Report:

• What is the size of gene therapy market?
• What is the CAGR and market size over the next five years?
• What are the different sub-markets and their worth/CAGR over the next five years?
• What is gene augmentation therapy?
• What is suicide gene therapy?
• How is ex vivo gene delivery different from in vivo gene delivery?
• What are the types of gene therapies classified on the basis of targeted cell types?
• What is the role of CRISPR technology in gene therapy?
• What are the approved gene therapy products?
• How many gene therapy product candidates have reached the Phase III stage?
• How many Phase II gene therapy product candidates are there?
• What is the commercialization status of gene therapies in E.U. member countries?
• What are the prices of gene therapy products?
• What are the reasons for this extortionate pricing of gene therapies?
• Which company is offering warranty for its gene- therapy product?
• What is the current strength of gene therapy industry?
• Is it true that the real strength of gene therapy industry is based on the number of clinical trials?
• What is the total number of ongoing clinical trials as of 2017?
• What is the distribution of clinical trials by geography?
• Which countries are associated with gene therapy clinical trials?
• What are the major indications addressed by the clinical trials?
• Which genes are transferred in these clinical trials?
• How many Big Pharma are associated with the Gene Therapy Industry?
• What are non-viral and viral vectors?
• What are the various features of viral vectors?
• Which viral vectors are predominantly used in gene therapy clinical trials?
• What are the major diseases addressed by therapeutic genes?
• Where is the gene therapy market heading, and what opportunities and challenges will it face?

Table of Contents:
1.0 Introduction
2.0 Gene Therapy: The Basics
3.0 Historic Overview of Gene Therapy
4.0 Gene Therapy Phase III Product Candidates
5.0 Gene Therapy Phase II Product Candidates
6.0 Commercialization, Cost and Warranty of Gene Therapies
7.0 The Strength of Gene Therapy Industry
8.0 Vectors for Gene Delivery
9.0 Clinical Applications of Gene Therapy
10.0 Market Analysis
11.0 Manufacturing of Viral Vectors and Logistics
12.0 Company Profiles

Contact Info:
Name: Hrishikesh Patwardhan
Email: Send Email
Organization: ReportsnReports

Source URL: https://marketersmedia.com/global-gene-therapy-market-analysis-phases-key-company-and-forecast-to-2022/443554

For more information, please visit https://www.reportsnreports.com/reports/1370259-global-gene-therapy-market-analysis-forecast-to-2022.html

Source: MarketersMedia

Release ID: 443554

More News From sports.morningdispatcher.com

World champion Hamilton wins season-ending Abu Dhabi GP

Dec 11, 2018

ABU DHABI, United Arab Emirates — World champion Lewis Hamilton coasted to victory from pole position at the season-ending Abu Dhabi Grand Prix on Sunday. Having already secured a fifth F1 title, the British Mercedes driver beat Ferrari's Sebastian Vettel at the Yas Marina circuit to secure his 11th win of the season and 73rd of his career. It was a symbolic finish to a season where, again, he showed his superiority under pressure to beat Vettel into second place overall for the second straight year. Red Bull driver Max Verstappen finished third ahead of teammate Daniel Ricciardo for a...

Recovering Lauda hopes to be back working with Mercedes soon

Dec 11, 2018

ABU DHABI, United Arab Emirates — Niki Lauda hopes to be back working with Mercedes soon as he continues his recovery from a lung transplant. The three-time Formula One champion appeared cheerful as he posted a message on the Mercedes team's Twitter account on Saturday. Speaking softly but clearly, Lauda says "the important message is I will be there soon" before thanking all his fans for the "unbelievable" support he has received. The 69-year-old Lauda, who received a new lung on Aug. 2, is non-executive chairman of Mercedes. He has had a close working relationship with five-time F1 champion Lewis...

England fights back against Sri Lanka to reach 259-6 at tea

Dec 11, 2018

KANDY, Sri Lanka — England fought back against Sri Lanka on Friday to reach 259-6 at tea on the third day of the second test, leading by 213 runs with four wickets in hand. England captain Joe Root, who is nearing his 15th test hundred, was unbeaten on 98 with Ben Foakes on 19 at the Pallekele International Stadium. At lunch, England was badly placed at 131-4, leading only by 85 runs. But the tourists took back control while losing only two wickets in the next session. Root and Jos Buttler added 74 runs for the fifth wicket. Buttler was...

Molinari 1 shot ahead of Fleetwood in race for European No 1

Dec 11, 2018

DUBAI, United Arab Emirates — Francesco Molinari missed two par putts from less than two feet in his opening round of the World Tour Championship on Thursday to give Tommy Fleetwood a sliver of a chance of keeping the European Tour season title. Molinari was cruising at one stage, having reached 6-under par after 14 holes, but three-putted the 15th and 18th holes to finish on 4-under 68 at Jumeirah Golf Estates. Fleetwood, his only remaining rival in the Race to Dubai, completed his bogey-free round with a wonderful 25-foot birdie putt from off the green on the par-5 18th,...

Silva pushes Sri Lanka to lead over England in 2nd test

Dec 11, 2018

KANDY, Sri Lanka — Sri Lanka fought back admirably against England thanks to a back-to-the-wall 85 by Roshen Silva to earn a first-innings lead of 46 runs in the second test on Thursday. However, Silva's failure to ground his bat and run short conceded a rare five penalty runs to England. Sri Lanka was all out for 336 in reply to England's 285, boosted to 290 with the penalty runs at Pallekele International Stadium. England faced just one over before stumps on day two and promoted Jack Leach to open the innings. The nightwatchman negotiated six deliveries from Dilruwan Perera...

About Us

Get all the up-to-date breaking news about politics, business, entertainment, sports, lifestyles, weather, traffic, and local news in a seamless digital environment only in Morning Dispatcher.

Contact us: sales[at]morningdispatcher.com

Subscribe Now!

Quick Links

HomePress